How Level Funded Gets Sold: The Broker as Distribution Channel, Advisor, and Gatekeeper

A 20-person company needs health coverage. The owner calls the broker, the same broker who placed the dental plan three years ago and helped with workers’ compensation last fall. The owner says: our renewal is coming up, the rates went up again, what can we do? The owner does not say: please evaluate whether a self-funded level funded plan with stop loss protection would produce better economics than our current fully insured contract. The owner does not know that option exists.

The broker translates the owner’s request into a product decision. In the small group market, this translation is the most consequential step in the entire distribution chain. Approximately 88 percent of small employers purchase or renew their employer-sponsored health insurance through an agent or broker, according to survey data from the Kaiser Family Foundation and NAHU-affiliated research. For a company with no benefits director, no HR department, and no internal actuarial capacity, the broker’s recommendation is the decision.

The Sales Process From the Employer’s Side

#

The standard small group renewal cycle begins 90 to 120 days before the plan year anniversary. The broker receives rate increase information from the incumbent carrier. For fully insured small group plans under 50 lives, carriers in most states file community-rated premiums that cannot be individually negotiated. A broker presenting an Anthem Blue Cross or Aetna fully insured quote for a 22-person group in Ohio receives the same rate as any other broker presenting the same plan design and census. The broker’s pricing leverage in the small group fully insured market is essentially zero. The only way to change the rate is to change the plan design, change the carrier, or change the funding structure.

This is where the distribution fork occurs. A broker with level funded capability runs a parallel set of quotes from one or more TPAs and stop loss carriers. The broker submits the same census to an independent level funded TPA, to UnitedHealthcare Level Funded, to Starmark (Trustmark’s level funded product), or to whichever TPAs the broker is contracted with. The level funded quotes come back showing a total monthly cost that includes the claims fund, the stop loss premium, and the administrative fee (LFP-01.01). The broker now has two fundamentally different product categories to present: a community-rated fully insured option with no claims risk and no surplus potential, and a medically underwritten level funded option with claims risk, surplus potential, and transparency into the cost components.

The employer’s decision depends almost entirely on how the broker presents this comparison. The KFF 2024 Employer Health Benefits Survey found that 53 percent of small firms (three to 199 workers) offered health benefits, compared with 98 percent of large firms. Among covered workers at firms with 10 to 199 employees, 37 percent were enrolled in a level funded plan as of the 2025 KFF survey. That penetration rate has grown substantially from the single digits a decade ago, but it still means the majority of small group covered workers are in fully insured or traditional self-funded arrangements. The gap between the product’s economic potential and its actual market penetration is, in significant part, a distribution gap.

Where the Broker Adds Value

#

A competent broker presenting both fully insured and level funded options provides the employer with an analysis the employer cannot produce independently. The comparison spans total cost, component transparency, claims risk exposure, surplus potential, plan design flexibility, and network access. In a fully insured quote, the employer sees a single premium number. In a level funded quote, the employer sees three separate cost components and can evaluate where the money goes (LFP-01.07). The broker who explains this distinction with analytical rigor gives the employer a decision framework that no carrier website or enrollment platform replicates.

TPA vetting is the second source of broker value. The employer has no mechanism for evaluating whether one independent TPA processes claims more accurately than National Benefit Services, or whether HealthSCOPE Benefits provides better stop loss coordination than some regional TPA the employer has never heard of. The broker who has placed business with multiple TPAs over multiple plan years has direct experience with claims turnaround times, reporting quality, member satisfaction, and renewal behavior. This vetting intelligence is expensive to develop and impossible for the employer to replicate from scratch. A broker who has placed 30 level funded groups over five years and tracked their performance has a data set that no published survey captures.

Plan design advisory represents a third value layer. Level funded plans permit design customization that the small group fully insured market does not. An employer can select deductible levels, cost-sharing structures, network configurations, and ancillary integration (LFP-11.01) with flexibility that community-rated fully insured products cannot match. The broker who understands plan design well enough to build a structure that fits the employer’s workforce composition, wage distribution, and utilization patterns is providing advice that materially affects the plan’s cost trajectory.

Renewal management is where broker value compounds over time. The renewal is the moment when the level funded value proposition is sustained or lost. A broker who uses the current plan year’s claims data to project renewal costs, identify high-cost claimants who may trigger stop loss lasers (LFP-02.04), and negotiate stop loss terms with the carrier is providing advisory work that no other intermediary supplies. The broker who waits for the TPA’s renewal letter and passes it through to the employer without analysis is not managing the renewal. The broker who analyzes the claims run rate at month eight and initiates stop loss marketing at month nine is providing the kind of data-informed advisory that justifies the broker’s position in the distribution chain.

Where the Gatekeeper Function Distorts the Market

#

The same structural position that enables broker value also enables broker distortion. If the broker lacks level funded capability, the employer never sees the option. The gatekeeper function operates through three channels.

The first is limited product access. Most brokers are contracted with a small number of TPAs, sometimes one, sometimes two or three. The employer sees the options the broker has, not the options the market has. If the broker’s TPA relationships are limited to a single carrier-affiliated product such as UnitedHealthcare Level Funded, the employer’s level funded comparison is artificially constrained to one product architecture. A broker contracted with both a national carrier-affiliated product and an independent level funded TPA provides a fundamentally different comparison set than a broker contracted with only one. The employer has no way to know what options were excluded.

The second is commission-driven steering. Broker compensation structures differ between fully insured and level funded placements. In the small group fully insured market, carriers commonly pay broker commissions of $25 to $40 per employee per month (PEPM). In some level funded arrangements, the broker commission is set at a similar PEPM, typically $20 to $50 PEPM, but the total compensation picture is complicated by overrides, production bonuses, and retention incentives that differ by carrier and TPA relationship (LFP-14.02). The broker’s financial incentive may not align with the employer’s interest in lower total cost and greater transparency. This is not a universal condition. Many brokers earn comparable or better compensation on level funded placements. But the variation in compensation structures across products creates a structural condition in which steering is possible and, for some broker practices, rational.

The third is insufficient actuarial knowledge. Level funded requires the broker to evaluate stop loss terms, understand specific and aggregate attachment points, explain the aggregate corridor and the employer’s risk within it, project claims experience for the employer’s population, and describe what happens if a member is lasered at renewal. Many generalist brokers lack this knowledge. The result is avoidance: the broker does not present level funded because the broker cannot explain it credibly. A broker who cannot answer the employer’s question about what happens if claims exceed the fund balance cannot responsibly recommend the product. The ASPE has documented that smaller employers are particularly reliant on brokers for plan design and selection decisions, making the broker’s knowledge gap a market constraint that directly affects employer access.

The Market Penetration Consequence

#

The KFF 2025 survey finding that 37 percent of covered workers at firms with 10 to 199 employees are in level funded plans represents substantial growth. But the Peterson-KFF Health System Tracker reported in 2025 that 44 percent of covered workers in firms with 10 to 49 employees were enrolled in a self-funded or level funded plan, a figure that includes traditional self-funded arrangements. An Urban Institute analysis in 2024 estimated that 45 percent of the entire small group market was enrolled in self-funded or level funded products, citing KFF data. Meanwhile, the fully insured small group market continues to lose enrollment. Mark Farrah Associates reported that small group fully insured membership declined another 7.0 percent in 2024, with small businesses opting to self-insure through level funded plans, switch to ICHRA, or drop coverage.

The growth is real, but the ceiling is determined by distribution, not demand. The product offers cost savings, transparency, and design flexibility that many small employers would prefer if they saw the option. The employers who do not see it fall into two categories: those whose brokers lack level funded capability and those whose brokers have the capability but choose not to present it.

The gatekeeper bottleneck is a larger constraint on level funded market growth than the actuarial constraints below 10 lives (LFP-02.08), larger than the regulatory patchwork across states (LFP-03.02), and larger than the employer awareness gap. Product innovation designed for the 1-to-50 market (LFP-15.01) that cannot move through the broker channel (LFP-14.05, LFP-15.08) will not reach the employers it is designed to serve. A TPA building a level funded product for small employers must solve the distribution problem or accept that product quality alone will not drive market penetration.

The Distribution Layer and What It Controls

#

The broker determines whether the employer sees level funded. The broker determines how it is compared to fully insured. The broker determines which TPA administers it. The broker determines how the renewal is managed and whether the employer understands the claims data that should inform the renewal decision.

The broker who does this well adds genuine value that no direct distribution channel currently replicates for the small group market. The broker who does it poorly constrains the market by filtering out a product category that would serve many employers better than the fully insured alternative they are shown. Understanding this gatekeeper function is prerequisite to designing distribution strategy for any product that moves through the broker channel. The product architecture (LFP-15.01) and the broker enablement tools (LFP-15.08) must be designed with the broker’s capabilities, limitations, and incentive structure as primary design constraints, not afterthoughts.